Literature DB >> 22259188

Genetic variation in GPX1 is associated with GPX1 activity in a comprehensive analysis of genetic variations in selenoenzyme genes and their activity and oxidative stress in humans.

Yumie Takata1, Irena B King, Johanna W Lampe, Raymond F Burk, Kristina E Hill, Regina M Santella, Alan R Kristal, David J Duggan, Thomas L Vaughan, Ulrike Peters.   

Abstract

Previous studies suggest some effects of selenium on risk of several chronic diseases, which may be mediated through a small number of selenoenzymes with antioxidant properties. In this cross-sectional analysis of 195 participants from the Seattle Barrett's Esophagus Study who were free of esophageal cancer at the time of blood draw, we examined whether the number of the minor alleles in 26 tagging single nucleotide polymorphisms (SNP) of five selenoenzyme genes [i.e., glutathione peroxidase 1-4 (GPX1-4) and selenoprotein P (SEPP1)] was associated with activity of GPX1 in white blood cells and GPX3 in plasma, and concentrations of SEPP1 and markers of oxidative stress [malondialdehyde (MDA) and protein carbonyl content] in plasma. At the gene level, associations were observed between overall variation in GPX1 and GPX1 activity (P = 0.02) as well as between overall variation in GPX2 and SEPP1 concentrations (P = 0.03). By individual SNP, two variants in GPX1 (rs8179164 and rs1987628) showed a suggestive association with GPX1 activity (P = 0.10 and 0.08, respectively) and two GPX2 variants (rs4902346 and rs2071566) were associated with SEPP1 concentration (P = 0.004 and 0.002, respectively). Furthermore, two SNP in the SEPP1 gene (rs230813 and rs230819) were associated with MDA concentrations (P = 0.03 and 0.02, respectively). Overall, our study supports the hypothesis that common genetic variants in selenoenzymes affect their activity.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22259188      PMCID: PMC3278265          DOI: 10.3945/jn.111.151845

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  53 in total

1.  Glutathione peroxidase isoforms as part of the local antioxidative defense system in normal and Barrett's esophagus.

Authors:  Hubert Mörk; Michael Scheurlen; Oliver Al-Taie; Annette Zierer; Michael Kraus; Katrin Schöttker; Franz Jakob; Josef Köhrle
Journal:  Int J Cancer       Date:  2003-06-20       Impact factor: 7.396

2.  Serum selenium levels in relation to markers of neoplastic progression among persons with Barrett's esophagus.

Authors:  Rebecca E Rudolph; Thomas L Vaughan; Alan R Kristal; Patricia L Blount; Douglas S Levine; Patricia C Galipeau; Laura J Prevo; Carissa A Sanchez; Peter S Rabinovitch; Brian J Reid
Journal:  J Natl Cancer Inst       Date:  2003-05-21       Impact factor: 13.506

3.  The UCSC Table Browser data retrieval tool.

Authors:  Donna Karolchik; Angela S Hinrichs; Terrence S Furey; Krishna M Roskin; Charles W Sugnet; David Haussler; W James Kent
Journal:  Nucleic Acids Res       Date:  2004-01-01       Impact factor: 16.971

4.  Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium.

Authors:  Christopher S Carlson; Michael A Eberle; Mark J Rieder; Qian Yi; Leonid Kruglyak; Deborah A Nickerson
Journal:  Am J Hum Genet       Date:  2003-12-15       Impact factor: 11.025

5.  Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase.

Authors:  D E Paglia; W N Valentine
Journal:  J Lab Clin Med       Date:  1967-07

6.  Expression profiling and genetic alterations of the selenoproteins GI-GPx and SePP in colorectal carcinogenesis.

Authors:  Oliver Hatem Al-Taie; Nurcan Uceyler; Ursula Eubner; Franz Jakob; Hubert Mörk; Michael Scheurlen; Regina Brigelius-Flohe; Katrin Schöttker; Josef Abel; Andreas Thalheimer; Tiemo Katzenberger; Bertram Illert; Ralf Melcher; Josef Köhrle
Journal:  Nutr Cancer       Date:  2004       Impact factor: 2.900

Review 7.  Making sense of sex and supplements: differences in the anticarcinogenic effects of selenium in men and women.

Authors:  David J Waters; Emily C Chiang; Dawn M Cooley; J Steven Morris
Journal:  Mutat Res       Date:  2004-07-13       Impact factor: 2.433

8.  Bacteria-induced intestinal cancer in mice with disrupted Gpx1 and Gpx2 genes.

Authors:  Fong-Fong Chu; R Steven Esworthy; Peiguo G Chu; Jeffrey A Longmate; Mark M Huycke; Sharon Wilczynski; James H Doroshow
Journal:  Cancer Res       Date:  2004-02-01       Impact factor: 12.701

9.  Genetic variants of GPX1 and SOD2 and breast cancer risk at the Ontario site of the Breast Cancer Family Registry.

Authors:  Julia A Knight; U Venus Onay; Sean Wells; Hong Li; Ellen J Q Shi; Irene L Andrulis; Hilmi Ozcelik
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2004-01       Impact factor: 4.254

10.  Sampling and analysis techniques for monitoring serum for trace elements.

Authors:  S P Ericson; M L McHalsky; B E Rabinow; K G Kronholm; C S Arceo; J A Weltzer; S W Ayd
Journal:  Clin Chem       Date:  1986-07       Impact factor: 8.327

View more
  11 in total

1.  Variation in selenoenzyme genes and prostate cancer risk and survival.

Authors:  Milan S Geybels; Carolyn M Hutter; Erika M Kwon; Elaine A Ostrander; Rong Fu; Ziding Feng; Janet L Stanford; Ulrike Peters
Journal:  Prostate       Date:  2012-11-09       Impact factor: 4.104

2.  Genetic variants in selenoprotein P plasma 1 gene (SEPP1) are associated with fasting insulin and first phase insulin response in Hispanics.

Authors:  Jacklyn N Hellwege; Nicholette D Palmer; Julie T Ziegler; Carl D Langefeld; Carlos Lorenzo; Jill M Norris; Toshinari Takamura; Donald W Bowden
Journal:  Gene       Date:  2013-10-24       Impact factor: 3.688

3.  Selenium, selenoenzymes, oxidative stress and risk of neoplastic progression from Barrett's esophagus: results from biomarkers and genetic variants.

Authors:  Yumie Takata; Alan R Kristal; Regina M Santella; Irena B King; David J Duggan; Johanna W Lampe; Margaret P Rayman; Patricia L Blount; Brian J Reid; Thomas L Vaughan; Ulrike Peters
Journal:  PLoS One       Date:  2012-06-08       Impact factor: 3.240

4.  Serum selenium and skin diseases among Nigerians with human immunodeficiency virus/acquired immune deficiency syndrome.

Authors:  Adeolu Oladayo Akinboro; David Ayodele Mejiuni; Olaniyi Onayemi; Olugbenga Edward Ayodele; Adeniran Samuel Atiba; Gbenga Micheal Bamimore
Journal:  HIV AIDS (Auckl)       Date:  2013-08-20

5.  Influence of Gender and SNPs in GPX1 Gene on Biomarkers of Selenium Status in Healthy Brazilians.

Authors:  Janaina L S Donadio; Elvira M Guerra-Shinohara; Marcelo M Rogero; Silvia M F Cozzolino
Journal:  Nutrients       Date:  2016-05-05       Impact factor: 5.717

6.  Identification of SEPP1 polymorphisms is not a genetic risk factor for preeclampsia in Chinese Han women: A clinical trial and experimental study.

Authors:  Hong Wu; Xuewen Jia; Hong Zhao; Youmin Huang; Chang Liu; Zuzhou Huang; Shunjun Li; Jingli Wang
Journal:  Medicine (Baltimore)       Date:  2017-07       Impact factor: 1.889

7.  Detection of metabolic syndrome burden in healthy young adults may enable timely introduction of disease prevention.

Authors:  Anja Šoštarič; Barbara Jenko; Nada Rotovnik Kozjek; Darja Ovijač; Dušan Šuput; Irina Milisav; Vita Dolžan
Journal:  Arch Med Sci       Date:  2019-08-23       Impact factor: 3.318

8.  Genome-wide association study of serum selenium concentrations.

Authors:  Jian Gong; Li Hsu; Tabitha Harrison; Irena B King; Stefan Stürup; Xiaoling Song; David Duggan; Yan Liu; Carolyn Hutter; Stephen J Chanock; Charles B Eaton; James R Marshall; Ulrike Peters
Journal:  Nutrients       Date:  2013-05-21       Impact factor: 5.717

9.  SEPP1 influences breast cancer risk among women with greater native american ancestry: the breast cancer health disparities study.

Authors:  Andrew J Pellatt; Roger K Wolff; Esther M John; Gabriela Torres-Mejia; Lisa M Hines; Kathy B Baumgartner; Anna R Giuliano; Abbie Lundgreen; Martha L Slattery
Journal:  PLoS One       Date:  2013-11-20       Impact factor: 3.240

10.  Case control feasibility study assessing the association between severity of coronary artery disease with Glutathione Peroxidase-1 (GPX-1) and GPX-1 polymorphism (Pro198Leu).

Authors:  Dinushka Wickremasinghe; Hemantha Peiris; Lal Gotabhaya Chandrasena; Vajira Senaratne; Rasika Perera
Journal:  BMC Cardiovasc Disord       Date:  2016-05-26       Impact factor: 2.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.